LANGEPHARM ApS: Financial statements 2021
CVR: 25198956
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
LANGEPHARM ApS (CVR 25198956) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -11,804 and a net result of DKK -9,353 compared with DKK -25,721 the year before. Equity in the 2021 report amounted to DKK 829,668. The solvency ratio was 92.6%.
- Gross Profit
- DKK -11,804
- Profit/Loss
- DKK -9,353
- Equity
- DKK 829,668
- Total Assets
- DKK 895,888
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -12 t. | -9 t. | 830 t. | 0 |
| 2020 | - | -33 t. | -26 t. | 839 t. | - |
| 2019 | - | 184 t. | 162 t. | 1.1 mio. | 0 |
| 2018 | - | 205 t. | 89 t. | 941 t. | 1 |
| 2017 | - | 197 t. | 104 t. | 852 t. | 1 |
Official annual report
Find more companies like LANGEPHARM ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
LANGEPHARM ApS has published its annual report for 2020. Gross profit came to DKK -32,976, and the net result was DKK -25,721.
About LANGEPHARM ApS
LANGEPHARM ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company has been dissolved on 29 March 2023. The company was registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named SKIN CARE CONSULTING ApS. The company has 0 employees (2018). In 2022, the company reported a gross profit of DKK -8,468 and a net result of DKK -6,610 compared with DKK -9,353 the year before. Equity in the 2022 report amounted to DKK 823,059.